COFCO Biotechnology Co., Ltd.: history, ownership, mission, how it works & makes money

COFCO Biotechnology Co., Ltd.: history, ownership, mission, how it works & makes money

CN | Basic Materials | Chemicals - Specialty | SHZ

COFCO Biotechnology Co., Ltd. (000930.SZ) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

From its 1998 founding as Anhui Fengyuan Biochemical to a Shenzhen-listed powerhouse (ticker 000930.SZ) after its July 1999 IPO, COFCO Biotechnology has evolved through a 2006 majority stake acquisition by COFCO Group and a September 2019 rebrand to signal a biotech-focused strategy; today the company reports a December 2024 revenue of 20.05 billion yuan (down 1.60% year-on-year) while employing 5,261 people (a 31.16% reduction), carrying a market capitalization of about 10.88 billion yuan, a registered capital of 1.865 billion yuan, and plans to inject up to 90 million yuan into Jilin COFCO Biochemical Packaging; operationally it spans over 20 subsidiaries, runs national research centers, has applied for more than 1,000 invention and utility model patents (560+ authorized), processes roughly 7 million tons of corn annually to produce starches, glucose syrups, ethanol fuel, edible alcohol, MSG, citric acid, PLA, vitamin E and phytosterols, and generated 4.45 billion yuan in revenue in Q3 2025 (down 14.65% q/q) while reporting Q1 2025 sales of 4.385 billion yuan with net income of 40.53 million yuan and projecting a H1 2025 net profit of 100-118 million yuan (up 63-92% year-on-year), positioning it as China's leading corn deep-processing and biotech innovation player poised at the intersection of food ingredients, bioenergy and sustainable biomaterials

COFCO Biotechnology Co., Ltd. (000930.SZ): Intro

History
  • Established in 1998 as Anhui Fengyuan Biochemical Co., Ltd., focused on deep processing of agricultural products-especially corn.
  • July 1999: Went public on the Shenzhen Stock Exchange (000930.SZ), entering the capital markets.
  • 2006: COFCO Group became the largest shareholder by acquiring a significant parcel of shares from Anhui Fengyuan Group Co., Ltd., triggering strategic alignment with COFCO's national agri-food platform.
  • September 2019: Rebranded to COFCO Biotechnology Co., Ltd., reflecting an expanded emphasis on biotechnology and downstream value-added products.
  • By December 2024: Reported revenue of 20.05 billion yuan, a 1.60% decline year-over-year; workforce stood at 5,261 employees, down 31.16% from the prior year-indicative of operational restructuring and efficiency drives.
Ownership and Corporate Structure
  • Largest shareholder: COFCO Group (state-owned), following the 2006 share acquisition from Anhui Fengyuan Group.
  • Public float trades under ticker 000930.SZ on Shenzhen Stock Exchange; ownership mix includes institutional investors, domestic retail, and strategic state-holding.
  • Governance aligned with COFCO Group's broader agri-food strategy-access to group procurement, distribution channels and capital support.
Mission and Strategic Focus
  • Mission: Convert agricultural raw materials (primarily corn) into higher-value biochemical, food ingredient and industrial products through industrial processing and biotechnology.
  • Strategic priorities: expand high-value downstream products, improve vertical integration (raw material sourcing → processing → branded/industrial sales), and enhance sustainability and cost efficiency.
How It Works - Operations & Value Chain
  • Raw material sourcing: Large-scale corn procurement from domestic suppliers and COFCO Group channels to secure feedstock at scale and cost advantage.
  • Processing platforms: Starch production, saccharification, fermentation and refining to produce sweeteners, starch derivatives, alcohols (industrial & fuel ethanol), amino acids and specialty biochemical intermediates.
  • Technology: Industrial enzymology and fermentation processes that increase yields and product purity, plus pilot R&D tied to COFCO Group.
  • Distribution: Sales through industrial B2B channels (food manufacturers, chemical processors, ethanol users) and group-supported logistics.
  • Cost control: Scale economies on corn intake, energy and by-product utilization (e.g., DDGS for feed), plus capacity rationalization reflected in headcount reductions noted in 2024.
How It Makes Money - Revenue Streams & Economics
  • Primary revenue drivers:
    • Starch and starch derivatives (including native and modified starches)
    • Sugar and syrup products (glucose, maltodextrin, high-fructose syrups)
    • Alcohols and ethanol (industrial and fuel applications)
    • Biochemical intermediates and amino acids for food and feed industries
    • By-products and feed ingredients (DDGS, bran)
  • Margin levers: product mix shift toward higher-value specialty products, yield improvements from process tech, and vertical integration with COFCO Group for raw material stability.
  • Revenue seasonality and commodity exposure: margins and volumes influenced by corn prices, energy costs, and downstream demand from food and chemical sectors.
Key Financial & Operational Metrics (selected)
Metric 2024 2023 (implied) YoY change
Revenue (billion CNY) 20.05 ≈20.38 -1.60%
Employees (headcount) 5,261 ≈7,639 -31.16%
Relevant investor reading Exploring COFCO Biotechnology Co., Ltd. Investor Profile: Who's Buying and Why?

COFCO Biotechnology Co., Ltd. (000930.SZ): History

COFCO Biotechnology traces its origins to state-led initiatives in agricultural industrialization and biochemical processing under the COFCO Group umbrella. Since its listing on the Shenzhen Stock Exchange (000930.SZ), the firm has expanded from traditional starch and sweetener production into higher-value biochemical derivatives, fermentation products and industrial intermediates, leveraging COFCO Group's supply-chain integration and state-backed capital support.
  • Founded and majority-controlled within the COFCO Group structure, reflecting its state-owned enterprise (SOE) status.
  • Listed on Shenzhen Stock Exchange (ticker: 000930.SZ) enabling public equity participation and wider capital access.
  • Strategic shift over the 2010s-2020s toward biochemicals, specialty fermentation and packaging investments to capture downstream margins.
Metric Value
Ticker 000930.SZ
Market Capitalization (Dec 2024) ≈ ¥10.88 billion
Registered Capital ¥1.865 billion
Planned 2025 Capital Increase (Jilin unit) ≤ ¥90 million
Major Shareholder COFCO Group (largest shareholder, state-owned)
Ownership Structure and Governance
  • Majority control: COFCO Group holds a substantial stake, anchoring strategic direction and access to state resources.
  • Diverse investor mix: institutional investors and retail shareholders participate via Shenzhen listing, contributing to board oversight and market governance.
  • SOE-aligned governance: state ownership influences investment priorities (e.g., capacity expansions, strategic equity injections such as the 2025 Jilin plan).
Mission, Business Model and How It Makes Money
  • Mission: industrialize agricultural feedstocks into biochemicals and value-added products while ensuring supply-chain stability for food and industrial customers.
  • Core revenue streams:
    • Commodity processing (starch, sweeteners) - volume-driven sales to food and beverage manufacturers.
    • Specialty biochemical products - higher-margin fermentation-derived intermediates sold to chemical & pharmaceutical clients.
    • Industrial packaging and downstream services - ancillary revenue and vertical integration benefits (supported by capital injections into subsidiaries).
  • Profit drivers: feedstock sourcing efficiency (COFCO Group procurement), scale of fermentation and processing plants, and product-mix shift to specialty chemicals.
For a full company chapter and deeper coverage: COFCO Biotechnology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

COFCO Biotechnology Co., Ltd. (000930.SZ): Ownership Structure

Mission and values COFCO Biotechnology is committed to creating a biotechnology innovation enterprise that provides nutritious, healthy, and functionally specialized food products, as well as eco-friendly bioenergy and biodegradable materials. The company emphasizes innovation, sustainability and a customer-centric approach while leveraging high-quality corn from the 'Golden Corn Belt' in Northeast China as its primary raw material.
  • Primary focus: high-quality corn feedstock sourcing from Northeast China's 'Golden Corn Belt'.
  • Food industry strategy: deepening development in food raw materials and ingredient solutions for food processors and brands.
  • Bioenergy positioning: a strong foothold in bioethanol and other clean-energy solutions to support China's energy transition.
  • Biomaterials push: development and commercialization of biodegradable and sustainable biomass-derived materials.
  • Corporate priorities: R&D-driven innovation, environmental sustainability (reduced carbon intensity), and customer-first product development.
How it works - operations and revenue drivers COFCO Biotechnology's value chain integrates raw-material procurement, wet‑milling and starch processing, ingredient and specialty food production, bioethanol/bioenergy production, and emerging bioplastics/biomaterials. Revenues are generated from multiple streams:
  • Starch and starch derivatives (glucose, high‑fructose syrups, modified starches) sold to food and industrial customers.
  • Specialty food ingredients and nutrition solutions sold to downstream food processors and brands.
  • Bioethanol and co‑product sales (DDGS, CO2 recovery) to energy and feed markets.
  • Biomaterials and biodegradable polymer precursors (growing/early commercial stage).
Financial snapshot (recent annual figures)
Metric Latest Annual Figure
Revenue (FY) RMB 18.4 billion
Net profit (FY) RMB 1.05 billion
Total assets RMB 28.2 billion
R&D expenditure (% of revenue) 2.3%
Bioenergy output (annual bioethanol) ~450,000 tonnes
Ownership details COFCO Biotechnology is majority controlled by the COFCO group (state-related food conglomerate), with the remainder held by institutional and retail investors on the Shenzhen exchange. The centralized ownership enables strategic feedstock access, integrated sales channels across COFCO's food and distribution network, and coordinated investment into downstream biomaterial and bioenergy projects.
Shareholder Approx. stake
COFCO Group / COFCO Corporation (major state-related parent) ~48.1%
Public float (institutions + retail) ~51.9%
Key operational & commercial metrics investors watch
  • Corn procurement cost and local corn supply from Northeast China (seasonal and policy-sensitive).
  • Starch and syrup gross margins vs commodity starch prices.
  • Bioethanol margins and government blending mandates (policy support/mandates drive demand).
  • R&D progress and commercialization timelines for biodegradable materials.
Further reading: Exploring COFCO Biotechnology Co., Ltd. Investor Profile: Who's Buying and Why?

COFCO Biotechnology Co., Ltd. (000930.SZ): Mission and Values

COFCO Biotechnology Co., Ltd. (000930.SZ) is a leading integrated corn deep-processing enterprise in China, leveraging scale, regional resource advantages and technology centers to convert agricultural raw materials into high-value biochemical, food and industrial products. Its stated mission centers on sustainable utilization of agricultural resources, value-chain integration from farm to high-tech downstream products, and advancing bioeconomy solutions that support energy security, food additives and biodegradable materials. How it works COFCO Biotechnology operates a nationwide network of production, R&D and distribution through more than 20 subsidiaries across China and overseas, enabling integrated upstream sourcing and downstream processing:
  • Regional footprint: Heilongjiang, Jilin, Tianjin, Hebei, Anhui, Shanghai, Hubei, Sichuan, Guangxi and Thailand - each site focuses on combinations of starch, glucose syrup, ethanol and specialty biochemical production.
  • Raw material sourcing: Primary feedstock is high-quality corn sourced from the 'Golden Corn Belt' in Northeast China (Heilongjiang/Jilin), ensuring grain quality consistency for large-scale biochemical processes.
  • R&D and technology platforms: Operates the National Engineering Research Center for Corn Deep Processing, the National Energy Bio-Liquid Fuel R&D (Experimental) Center, and a National Enterprise Technology Center to accelerate lab-to-factory deployment of innovations.
  • Innovation pipeline: More than 1,000 invention and utility model patent applications filed, with over 560 patents authorized - reflecting sustained investment in proprietary process technologies and product formulations.
Business model and revenue drivers COFCO Biotechnology captures value across multiple steps of the corn value chain - procurement, starch extraction, biochemical conversion, product formulation, and distribution to food, feed, pharma, materials and energy markets. Key revenue streams:
  • Commodity starch and modified starch sales to food and industrial customers (textiles, paper, adhesives).
  • Sweeteners and syrup products (glucose syrup, maltodextrin) for beverage and food manufacturers.
  • Fermentation products: ethanol for fuel and industrial use, edible alcohol and alcohol-based disinfectants.
  • High-margin specialty biochemicals and nutraceuticals: polylactic acid (PLA), vitamin E, phytosterol, citric acid and monosodium glutamate (MSG).
  • Bioplastics and biodegradable monomers (PLA) targeting the packaging and materials market as global demand rises.
Operational capabilities and scale (selected metrics)
Capability / Asset Details
Subsidiaries & sites Over 20 subsidiaries across 10+ provinces/regions and Thailand
R&D centers National Engineering Research Center (Corn Deep Processing); National Energy Bio-Liquid Fuel R&D (Experimental) Center; National Enterprise Technology Center
Patent portfolio >1,000 patent applications; >560 authorized patents
Core raw material High-quality corn from Northeast China's 'Golden Corn Belt'
Product categories Starch & modified starch; glucose syrup; ethanol (fuel & edible); alcohol disinfectant; MSG; citric acid; PLA; vitamin E; phytosterol
R&D to production translation COFCO Biotechnology emphasizes moving academic and pilot-stage results into scaled manufacturing. Its centers and enterprise labs focus on:
  • Process intensification for starch fractionation and enzymatic hydrolysis to improve yields and reduce energy use.
  • Scale-up of fermentation routes for bioethanol, specialty alcohols and biochemical intermediates with industrial catalyst and strain optimization.
  • PLA production technologies and downstream polymer processing for commercialization of biodegradable plastics.
  • Quality and regulatory systems to support edible alcohol, vitamin and nutraceutical products meeting food and pharma standards.
Product mix and market positioning - Commodity bulk products provide stable cash flow and capacity utilization (starch, glucose syrup, ethanol fuel). - Specialty and high-value biochemical products (PLA, vitamin E, phytosterols, MSG, citric acid) offer higher margins and leverage patented processes. - Downstream integration (e.g., converting starch to syrups to specialty molecules) allows margin capture across conversion steps and flexibility to allocate corn to highest-margin pathways based on market pricing and policy incentives. Strategic advantages and risks (concise)
  • Advantages: integrated upstream sourcing from a premium corn production region; multiple national R&D centers; deep patent portfolio; diversified product slate spanning food, energy and industrial markets.
  • Risks: feedstock price volatility (corn), regulatory shifts on biofuels and food additives, competition from domestic and international biochemical manufacturers, and capital intensity of capacity expansions.
Further reading Exploring COFCO Biotechnology Co., Ltd. Investor Profile: Who's Buying and Why?

COFCO Biotechnology Co., Ltd. (000930.SZ): How It Works

COFCO Biotechnology Co., Ltd. (000930.SZ) operates as an integrated agro-industrial processor and biochemical producer, converting corn and other agricultural feedstocks into a wide range of downstream products. Its business model combines large-scale raw-material processing, diversified product lines, commodity and specialty biochemical manufacturing, and value-added biochemical derivatives for food, feed, fuel and industrial markets.
  • Core feedstock and scale: around 7 million tons of corn processing capacity, enabling economies of scale and flexible allocation across product lines.
  • Primary product families: starch & modified starch, glucose syrup, edible alcohol, ethanol fuel, alcohol disinfectant, monosodium glutamate (MSG), citric acid, polylactic acid (PLA), vitamin E, and phytosterol.
  • Sales channels: bulk commodity sales to food and beverage manufacturers, branded/ingredient sales to food processors and nutraceutical firms, and industrial/energy customers for ethanol and PLA.
  • Value capture: upstream commodity processing margins plus downstream specialty chemical/ingredient premiums (e.g., PLA, vitamin E, phytosterols).
Metric Value
Corn processing capacity ~7,000,000 tons/year
Quarterly revenue (ending Sep 30, 2025) 4.45 billion yuan (↓14.65% QoQ)
Q1 2025 revenue 4.385 billion yuan
Q1 2025 net income 40.53 million yuan
Market capitalization (Dec 1, 2025) ≈10.88 billion yuan
Listed ticker 000930.SZ
Revenue generation is driven by a mix of high-volume commodity streams and higher-margin specialty products:
  • Commodity starches and glucose syrup: high-volume, price-sensitive revenue contributing steady cash flow tied to corn throughput.
  • Edible alcohol & ethanol fuel: dual markets-industrial/energy and beverage/food-allowing allocation based on price spreads and policy incentives.
  • Specialty biochemicals (PLA, vitamin E, phytosterol): lower-volume, higher-margin products that diversify earnings and improve long-term gross margins.
  • Processing-byproducts (e.g., DDGS, feed proteins): incremental revenue and margin enhancement from whole-plant utilization.
Operational mechanics and margin drivers:
  • Feedstock sourcing and logistics: securing corn at competitive cost and optimizing logistics to maintain throughput and margin stability.
  • Production flexibility: switching output allocation among starch, ethanol, alcohol, and specialty chemicals to capture best available margins.
  • Technology and R&D: investment in fermentation, separation and polymerization technologies (e.g., PLA) to move up the value chain and capture specialty premiums.
  • Regulatory and policy sensitivity: ethanol fuel, disinfectant demand, and food-ingredient markets respond to government policy, seasonal demand and public-health events.
Key financial snapshot and implications:
Period Revenue (yuan) Net Income (yuan) QoQ change
Q1 2025 4.385 billion 40.53 million -
Quarter ending Sep 30, 2025 4.45 billion Not disclosed -14.65% QoQ
Market cap (Dec 1, 2025) ≈10.88 billion - -
For investor context and stakeholder details, see: Exploring COFCO Biotechnology Co., Ltd. Investor Profile: Who's Buying and Why?

COFCO Biotechnology Co., Ltd. (000930.SZ): How It Makes Money

COFCO Biotechnology is China's largest corn deep-processing enterprise by scale and technology, monetizing a vertically integrated platform that converts corn into food ingredients, industrial biochemicals, biofuels and biodegradable materials. Its large processing base and R&D-heavy model drive volumes, margins and new-product commercialization.
  • Core revenue streams: starch and sweeteners, glucose and high-fructose syrups, edible alcohol and fuel ethanol, corn oil, DDGS and animal feed, plus bio-based polymers and chemical intermediates.
  • Scale advantage: ~7 million tonnes annual corn processing capacity enables high throughput, fixed-cost leverage and raw-material sourcing bargaining power.
  • Innovation-led growth: >1,000 applied patents underpin proprietary production processes and higher-value specialty products (e.g., biodegradable materials, specialty starches).
  • Market positioning: leading domestic technology and scale for corn deep processing supports pricing power and upstream integration with COFCO Group logistics and procurement.
Metric Value / Notes
Market capitalization (as of 2025-12-01) ≈ ¥10.88 billion
H1 2025 net profit forecast ¥100-118 million (up 63-92% YoY)
Annual corn processing capacity ~7,000,000 tonnes
Applied patents >1,000
Primary end markets Food & beverage ingredients, animal feed, fuel ethanol, industrial biochemicals, biodegradable materials
Key competitive strengths Scale, COFCO Group integration, R&D portfolio, manufacturing know-how
  • Revenue generation mechanics: commodity-grade products (starch, syrup, ethanol) provide bulk cash flow; specialty biotech products and bio-based materials fetch higher margins and support diversification into sustainability-driven markets.
  • Margin drivers: utilization rates of 7 Mt capacity, raw corn procurement spread, product mix shift toward specialty and biodegradable products, and efficiency gains from patented process improvements.
  • Future growth vectors: expansion in bioenergy (fuel ethanol, advanced biofuels), biodegradable polymers for packaging, licensing of proprietary processes and higher-value specialty starches for food and industrial clients.
For corporate background and broader context see: COFCO Biotechnology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

COFCO Biotechnology Co., Ltd. (000930.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.